Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Using AI, one can find cancer risk factors.

2.

Common intracellular toxin could help fight leukemia

3.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot